Mustang Bio, Inc. Profile Avatar - Palmy Investing

Mustang Bio, Inc.

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene the…

Biotechnology
US, Worcester [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Mustang Bio, Inc. has no acquisition track records yet.

M&A Deals · History

Mustang Bio, Inc. has no acquisition track records yet.

End of MBIO's Analysis
CIK: 1680048 CUSIP: 62818Q104 ISIN: US62818Q2030 LEI: - UEI: -
Secondary Listings
MBIO has no secondary listings inside our databases.